A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Pimodivir in Combination with the Standard-of-care Treatment in Adolescent, Adult, and Elderly Hospitalized Patients with influenza A infection